The global companion diagnostic tests in oncology market is anticipated to display phenomenal growth due to rising adoption of new tests, and shift from blockbuster drugs to personalized drugs and targeted therapies. Rising prevalence of cancer, increasing financial burden of cancer treatment, and increasing mortalities due to cancer are some of the major reasons for increasing demand for new and advanced ... Read more

The global Leptospirosis market is estimated to be valued at US$ 496.8 million in 2023 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Leptospirosis is a bacterial infection caused by the Leptospira species, primarily transmitted through urine of infected animals. The market offers diagnostic tests, antibiotics, and vaccines for the ... Read more